International Stem Cell Corporation Revenue per Employee (ISCO), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
International Stem Cell Corporation  (ISCO)
 

International Stem Cell's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 9.32% in the second quarter 2026, year on year to cumulative value of $10 million, International Stem Cell's revenue per employee grew on a trailing twelve months basis to $ 288,303. The productivity of International Stem Cell's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 332 other companies have achieved higher revenue per employee. While International Stem Cell's total ranking has deteriorated compared to the previous quarter from 2347 to 2619. International Stem Cell has 33 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ISCO Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change 9.32 % 8.74 % -11.9 % 8.72 % 4.98 %
Sales per Employee (TTM) $ 288,303 281,394 275,758 284,576 278,818
ISCO's Total Ranking # 2619 # 2347 # 2409 # 685 #
Seq. Revenue Change 15.55 % 7.42 % -9.03 % -3.19 % 14.94 %

ISCO Company Profile >> Back to ISCO Efficiency Comparisons >> Compare ISCO Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 137
Healthcare Sector # 333
Overall Market # 2619

Revenue per Employee Statistics
High Average Low
$ 336,030 $ 235,366 $ 122,294
(Dec 31 2018)   (Jun 30 2012)



Financial Statements
International Stem Cell's Revenue MRQ $ 3 Millions Visit ISCO's Income Statement
International Stem Cell's Revenues TTM $ 10 Millions Visit ISCO's aggregate revenue growth
What are ISCO's Sales? Visit ISCO's Sales by Segment




Other Ratios
International Stem Cell's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ISCO's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ISCO's Competitors
Revenue per Employee for ISCO's Suppliers
Revenue per Employee for ISCO's Customers

You may also want to know
ISCO's Sales Growth Rates ISCO's Pe Price to earnings ratio ISCO's Receivables Turnover Ratio ISCO's Stock Quote
ISCO's Net Income Growth Rates ISCO's Ps Price to Sales ratio ISCO's Sales per Employee ISCO's Asset Turnover Ratio
ISCO's Net Margin ISCO's Pb Price to Book ratio ISCO's Financial Strength Ratios ISCO's Dividend Payout Ratio
Date modified: 2026-09-03T21:08:49+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Angiodynamics Inc   502,731.01 $ 317.726  Million 632 
Zimmer Biomet Holdings Inc   500,517.65 $ 8,508.800  Million 17,000 
Biofrontera Inc   499,521.74 $ 45.956  Million 92 
Accuray Incorporated  495,467.24 $ 400.833  Million 809 
Resmed Inc   495,001.76 $ 5,628.170  Million 11,370 
Adaptive Biotechnologies Corporation  493,719.55 $ 308.081  Million 624 
Carlsmed Inc   491,787.40 $ 62.457  Million 127 
Viatris Inc   491,243.33 $ 14,737.300  Million 30,000 
Invivyd Inc   478,401.64 $ 58.365  Million 122 
Maravai Lifesciences Holdings Inc   477,898.85 $ 207.886  Million 435 
Moderna Inc   474,042.55 $ 2,228.000  Million 4,700 
Guardant Health Inc   472,108.94 $ 1,183.105  Million 2,506 
Neuropace Inc   471,866.03 $ 98.620  Million 209 
Skinhealth Systems Inc   471,817.29 $ 289.224  Million 613 
Pelthos Therapeutics Inc   470,695.65 $ 43.304  Million 92 
Inogen Inc   470,523.24 $ 354.304  Million 753 
Regenxbio Inc   470,301.89 $ 174.482  Million 371 
4d Molecular Therapeutics Inc   469,428.57 $ 92.008  Million 196 
Stryker Corp  461,375.00 $ 25,837.000  Million 56,000 
Atara Biotherapeutics Inc   460,857.14 $ 6.452  Million 14 
Glaukos Corp  457,066.73 $ 500.031  Million 1,094 
Treace Medical Concepts Inc   456,237.78 $ 205.307  Million 450 
Medpace Holdings Inc   448,756.13 $ 2,782.288  Million 6,200 
Sight Sciences Inc   448,123.66 $ 83.351  Million 186 
Haemonetics Corporation  447,145.88 $ 1,351.722  Million 3,023 
Nakamoto Inc   445,571.28 $ 28.962  Million 65 
Livanova Plc  445,488.48 $ 1,470.112  Million 3,300 
Rockwell Medical inc   444,757.96 $ 69.827  Million 157 
Trisalus Life Sciences Inc   442,931.37 $ 45.179  Million 102 
Kymera Therapeutics Inc   441,176.47 $ 105.000  Million 238 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.